Brief: Yichang Hec Changjiang Pharmaceutical Enters Deal With CR Pharmaceutical Commercial
03/01/2020 09:29
Jan 3 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* ENTERED STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH
CHINA
RESOURCES PHARMACEUTICAL COMMERCIAL GROUP
* UNDER AGREEMENT, CO & CR PHARMACEUTICAL COMMERCIAL WILL
JOINTLY
DEVELOP INTERNET PLATFORM
Source text for Eikon: ID:nHKS9JYVBl
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million